Health Advances Boston
Conducted regulatory intelligence for vaccine development and regulatory strategy in Ethiopia, Nigeria, and the Democratic Republic of the Congo.
01The challenge
Health Advances Boston faced complex regulatory landscapes across multiple African countries for their vaccine development projects. Navigating diverse regulatory requirements in Ethiopia, Nigeria, and the DRC required specialized knowledge of local pharmaceutical regulations and stakeholder dynamics.
02Our solution
ECP provided comprehensive regulatory intelligence and strategic guidance, including market analysis, regulatory pathway mapping, and stakeholder engagement. Our team delivered up-to-date intelligence on vaccine development requirements and facilitated communication with regulatory authorities across the three countries.
03Results
The collaboration enabled successful vaccine development and market entry in Ethiopia, Nigeria, and the DRC. Health Advances Boston benefited from streamlined regulatory processes and enhanced compliance, demonstrating ECP's expertise in multi-country African regulatory environments.
- Developed regulatory strategies for vaccine development in three countries
- Provided comprehensive regulatory intelligence and market analysis
- Facilitated stakeholder engagement and authority communications
- Achieved successful market entry and compliance across target markets
“ECP's regulatory intelligence was crucial for our vaccine development projects across multiple African countries. Their deep understanding of local requirements helped us navigate complex regulatory landscapes effectively.”Health Advances Boston Project Lead
Other case studies.
Grünenthal Pharmaceutical Project
Provided regulatory intelligence and guidance for branded generic registrations and regulatory maintenance in Kenya.
World Bank - EBA Project
Delivered regulatory framework intelligence for the Efficient Business for Agriculture (EBA) project, impacting veterinary product registration and importation in Kenya.
GSK Projects
Supported PAREXEL's GSK Vx Divestment project, regulatory strategy for Kenya and Nigeria, and restructuring of pharmaceutical operations in Sub-Saharan Africa.
Ready to navigate Africa’s regulatory landscape?
Tell us about your product and target markets. An ECP specialist will respond with a clear next step.